A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 2,533 shares of VRTX stock, worth $1.27 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,533
Previous 2,420 4.67%
Holding current value
$1.27 Million
Previous $1.13 Million 3.88%
% of portfolio
0.05%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$460.0 - $505.78 $51,980 - $57,153
113 Added 4.67%
2,533 $1.18 Million
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $269,467 - $333,073
-686 Reduced 22.09%
2,420 $1.13 Million
Q1 2024

Apr 30, 2024

BUY
$407.69 - $446.08 $156,552 - $171,294
384 Added 14.11%
3,106 $1.3 Million
Q4 2023

Jan 30, 2024

BUY
$343.0 - $410.68 $16,464 - $19,712
48 Added 1.8%
2,722 $1.11 Million
Q1 2023

May 10, 2023

SELL
$283.23 - $323.1 $71,090 - $81,098
-251 Reduced 8.58%
2,674 $842,000
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $32,005 - $36,005
-112 Reduced 3.69%
2,925 $844,000
Q3 2022

Oct 26, 2022

SELL
$273.83 - $305.53 $32,585 - $36,358
-119 Reduced 3.77%
3,037 $878,000
Q2 2022

Aug 10, 2022

SELL
$234.96 - $292.55 $226,501 - $282,018
-964 Reduced 23.4%
3,156 $889,000
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $139,494 - $164,411
-630 Reduced 13.26%
4,120 $1.07 Million
Q3 2021

Nov 02, 2021

BUY
$181.39 - $202.99 $440,777 - $493,265
2,430 Added 104.74%
4,750 $861,000
Q2 2021

Jul 27, 2021

BUY
$187.49 - $221.1 $252,549 - $297,821
1,347 Added 138.44%
2,320 $467,000
Q4 2020

Feb 09, 2021

BUY
$207.01 - $276.09 $50,924 - $67,918
246 Added 33.84%
973 $229,000
Q3 2020

Oct 20, 2020

SELL
$255.65 - $303.1 $44,227 - $52,436
-173 Reduced 19.22%
727 $197,000
Q2 2020

Jul 02, 2020

SELL
$225.48 - $295.8 $87,711 - $115,066
-389 Reduced 30.18%
900 $261,000
Q1 2020

Apr 01, 2020

SELL
$199.77 - $247.81 $5,194 - $6,443
-26 Reduced 1.98%
1,289 $306,000
Q4 2019

Feb 11, 2020

BUY
$166.71 - $223.91 $4,334 - $5,821
26 Added 2.02%
1,315 $287,000
Q3 2019

Oct 09, 2019

BUY
$166.23 - $187.09 $831 - $935
5 Added 0.39%
1,289 $218,000
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $211,359 - $244,435
1,284 New
1,284 $235,000
Q2 2018

Aug 16, 2018

SELL
$145.72 - $169.96 $1,311 - $1,529
-9 Closed
0 $0
Q4 2017

Feb 08, 2018

BUY
$137.28 - $155.55 $1,235 - $1,399
9
9 $1,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.